Rimonabant

Artikelnummer	Größe	Lieferzeit	Preis
TGM-T1519L-10mg	10 mg	7 - 10 Werktage*	42,00 €
TGM-T1519L-1mL	1 ml	7 - 10 Werktage*	55,00 €
TGM-T1519L-25mg	25 mg	7 - 10 Werktage*	83,00 €
TGM-T1519L-50mg	50 mg	7 - 10 Werktage*	131,00 €
TGM-T1519L-100mg	100 mg	7 - 10 Werktage*	195,00 €

Bei Fragen nutzen Sie gerne unser Kontaktformular.
Bestellen Sie auch per E-Mail: info@biomol.com
Größere Menge gewünscht? Bulk-Anfrage

Description: Rimonabant (SR141716) is an inverse agonist for the cannabinoid receptor CB1. It is... mehr

Menü schließen

Produktinformationen "Rimonabant"

Description: Rimonabant (SR141716) is an inverse agonist for the cannabinoid receptor CB1. It is an anorectic anti-obesity drug produced and marketed by Sanofi-Aventis. Its main avenue of effect is a reduction in appetite. Rimonabant is the first selective CB1 receptor blocker to be approved for use anywhere in the world. Rimonabant is approved in 38 countries including the E.U., Mexico, and Brazil. It was rejected for approval for use in the United States. Target: Cannabinoid Receptor, Acyltransferase, Antibacterial. Smiles: Cc1c(nn(c1-c1ccc(Cl)cc1)-c1ccc(Cl)cc1Cl)C(=O)NN1CCCCC1. References: Chu CM, et al, Org Biomol Chem, 2008, 6(18), 3399-3407

Schlagworte:	SR141716
Hersteller:	TargetMol
Hersteller-Nr:	T1519L

Eigenschaften

Anwendung:	Targets cannabinoid receptor 1 (CNR1)
MW:	463.79 D
Formel:	C22H21Cl3N4O

Datenbank Information

CAS :	168273-06-1\| Passende Produkte
KEGG ID :	K04277 \| Passende Produkte

Handhabung & Sicherheit

Lagerung:	-20°C
Versand:	+4°C (International: +4°C)
Signalwort:	Danger
GHS-Piktogramme:
H-Sätze:	H372, H410
P-Sätze:	P260, P264, P270, P273, P314, P391, P501